Silicone vs Non-Silicone Stents for Kidney Stones
(BLUES Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two types of stents used after ureteroscopy, a procedure for treating kidney stones. The researchers aim to determine if a silicone stent performs better than a non-silicone stent for individuals with kidney stones. Participants will receive one of the stents and report their post-procedure experiences. This trial suits those diagnosed with kidney stones on one side and planning to undergo ureteroscopy. As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance future kidney stone treatments.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these stents are safe for kidney stone treatment?
Research has shown that silicone ureteral stents, such as the Imajin stent, are generally safe. They typically cause less pain and fewer urinary issues than other stent types. Studies have not identified any major problems with silicone stents.
For stents made from other materials, research also supports their safety, though they may cause more discomfort than silicone stents. Many patients experience symptoms like frequent urination or urgency, but these are usually manageable.
Both silicone and non-silicone stents are considered safe, but silicone stents may offer a more comfortable experience.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for kidney stones because they explore the potential benefits of different stent materials. Unlike traditional stents, which are often made of materials like polyurethane, this trial is examining whether silicone stents, like the Coloplast Imajin Hydro, could offer improved patient comfort and effectiveness. Silicone is known for its flexibility and biocompatibility, which might reduce irritation and complications. By comparing these materials directly, researchers hope to discover which type of stent offers the best outcomes for patients undergoing ureteroscopy for kidney stones.
What evidence suggests that this trial's stents could be effective for kidney stones?
This trial will compare silicone ureteral stents with non-silicone ureteral stents for patients with kidney stones. Research has shown that silicone ureteral stents, which participants in one arm of this trial may receive, might be better for patients. Studies have found that silicone stents cause less discomfort and pain than non-silicone ones. Specifically, patients with silicone stents reported less pain two weeks before their stent removal. Additionally, silicone stents are recommended for patients with kidney stones due to fewer side effects. Non-silicone stents, such as those made from polyurethane, remain common but might not be as comfortable. Overall, early findings suggest that silicone stents could offer a more comfortable option for those treated for kidney stones.13678
Who Is on the Research Team?
Khurshid Ghani, MD, MS, FRCS
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
The BLUES trial is for individuals with kidney or ureter stones who can take oral medication and are willing to follow the study's procedures. They must have stones no larger than 2cm, need a stent without a string after surgery, and be able to complete surveys. Pregnant women, those allergic to polyurethane or silicone, with certain anatomical anomalies or prior urinary diversions cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to receive either the Imajin silicone stent or a non-silicone stent after ureteroscopy
Follow-up
Participants complete questionnaires and have follow-up information collected to assess outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Non-silicone (Polyurethane/Percuflex) ureteral stent (any manufacturer)
- Silicone (Coloplast Imajin Hydro) ureteral stent
- Ureteroscopy
Ureteroscopy is already approved in European Union, United States, Canada, Japan for the following indications:
- Renal calculi
- Ureteral calculi
- Upper urinary tract calculi
- Nephrolithiasis
- Ureteral obstruction
- Kidney stones
- Ureteral stones
- Urinary tract obstruction
- Hematuria
- Ureteral tumors
- Renal calculi
- Ureteral calculi
- Upper urinary tract calculi
- Nephrolithiasis
- Ureteral obstruction
- Kidney stones
- Ureteral stones
- Urinary tract obstruction
- Hematuria
- Ureteral tumors
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Coloplast A/S
Industry Sponsor
Kristian Villumsen
Coloplast A/S
Chief Executive Officer since 2018
Master's degree in Political Science from Aarhus University
Preeti Jain
Coloplast A/S
Chief Medical Officer since 2023
MD from University of Copenhagen